Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
188
-
Total 13F shares, excl. options
-
32.7M
-
Shares change
-
+1.16M
-
Total reported value, excl. options
-
$1.04B
-
Value change
-
+$36M
-
Put/Call ratio
-
1.47
-
Number of buys
-
86
-
Number of sells
-
-92
-
Price
-
$31.82
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q3 2018
246 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q3 2018.
Editas Medicine, Inc. - Common Stock (EDIT) has 188 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.7M shares
of 82.8M outstanding shares and own 39.46% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (3.73M shares), BlackRock Inc. (3.59M shares), STATE STREET CORP (2.92M shares), ARK Investment Management LLC (2.79M shares), Capital World Investors (2.03M shares), MORGAN STANLEY (1.73M shares), FMR LLC (1.52M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.16M shares), Viking Global Investors LP (931K shares), and CREDIT SUISSE AG/ (783K shares).
This table shows the top 188 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.